Практические аспекты диагностики и коррекции калий- и магнийдефицитных состояний. Мнение экспертов

калий, магний, гипокалиемия, гипомагниемия, факторы риска, сердечно-сосудистые заболевания, алгоритмы лечения, пищевое потребление, профилактика, аритмия

1. Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346(3):f1378–f1378. DOI: 10.1136/bmj.f1378

2. World Health Organization. A global brief of hypertension. Silent killer, global public health crisis. World health day. 2013. [Document number : WHO/DCO/WHD/2013.2. Available at: http://ish-world.com/downloads/pdf/global_brief_hypertension.pdf ]

3. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. The Lancet. 2016;387(10022):957–67. DOI: 10.1016/S01406736(15)01225-8

4. World Health Organization. Guideline: potassium intake for adults and children. -Geneva: WHO;2012. 52 p. ISBN 978-92-4-150482-9

5. Filippini T, Violi F, D’Amico R, Vinceti M. The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysis. International Journal of Cardiology. 2017;230:127–35. DOI: 10.1016/j.ijcard.2016.12.048

6. Haddy FJ, Vanhoutte PM, Feletou M. Role of potassium in regulating blood flow and blood pressure. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2006;290(3):R546– 52. DOI: 10.1152/ajpregu.00491.2005

7. Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y. Inwardly Rectifying Potassium Channels: Their Structure, Function, and Physiological Roles. Physiological Reviews. 2010;90(1):291–366. DOI: 10.1152/physrev.00021.2009

8. Khaw K-T, Barrett-Connor E. Dietary Potassium and Stroke-Associated Mortality. A 12-year prospective population study. New England Journal of Medicine. 1987;316(5):235–40. DOI: 10.1056/NEJM198701293160502

9. Ascherio A, Rimm EB, Hernán MA, Giovannucci EL, Kawachi I, Stampfer MJ et al. Intake of Potassium, Magnesium, Calcium, and Fiber and Risk of Stroke Among US Men. Circulation. 1998;98(12):1198–204. DOI: 10.1161/01.CIR.98.12.1198

10. He FJ, MacGregor GA. Fortnightly review: Beneficial effects of potassium. BMJ. 2001;323(7311):497–501. DOI: 10.1136/bmj.323.7311.497

11. Kimura M, Lu X, Skurnick J, Awad G, Bogden J, Kemp F et al. Potassium Chloride Supplementation Diminishes Platelet Reactivity in Humans. Hypertension. 2004;44(6):969–73. DOI: 10.1161/01.HYP.0000147660.58694.6f

12. Iso H, Stampfer MJ, Manson JE, Rexrode K, Hennekens CH, Colditz GA et al. Prospective Study of Calcium, Potassium, and Magnesium Intake and Risk of Stroke in Women. Stroke. 1999;30(9):1772– 9. DOI: 10.1161/01.STR.30.9.1772

13. D’Elia L, Barba G, Cappuccio FP, Strazzullo P. Potassium Intake, Stroke, and Cardiovascular Disease. Journal of the American College of Cardiology. 2011;57(10):1210–9. DOI: 10.1016/j.jacc.2010.09.070

14. Larsson SC, Orsini N, Wolk A. Dietary Potassium Intake and Risk of Stroke: A Dose–Response Meta-Analysis of Prospective Studies. Stroke. 2011;42(10):2746–50. DOI: 10.1161/STROKEAHA.111.622142

15. Compton SJ, Lux RL, Ramsey MR, Strelich KR, Sanguinetti MC, Green LS et al. Genetically Defined Therapy of Inherited Long-QT Syndrome: Correction of Abnormal Repolarization by Potassium. Circulation. 1996;94(5):1018–22. DOI: 10.1161/01.CIR.94.5.1018

16. Cohen JD, Neaton JD, Prineas RJ, Daniels KA. Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial. The American Journal of Cardiology. 1987;60(7):548–54. DOI: 10.1016/0002-9149(87)90303-1

17. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265(24):3255–64. PMID: 2046107

18. He FJ, MacGregor GA. Beneficial effects of potassium on human health. Physiologia Plantarum. 2008;133(4):725–35. DOI: 10.1111/j.1399-3054.2007.01033.x

19. Аверин Е.Е., Никитин И.Г., Никитин А.Э. Гипокалиемия: обзор современного состояния проблемы. Медицинский алфавит. 2018;3(32(369)):12-8

20. Барышникова Г.А., Аверин Е.Е. Альдостерон при артериальной гипертензии: новые терапевтические возможности. Consilium Medicum. 2013;15(10):18-23

21. Компаниец О.Г., Аверин Е.Е. Приоритеты выбора диуретиков при лечении гипертонической болезни: доказательная медицина, рекомендательные документы и реальная клиническая практика. Системные гипертензии. 2013;10(1):62-5

22. Барышникова Г.А., Аверин Е.Е. Применение диуретиков при артериальной гипертензии: преимущества торасемида. Эффективная фармакотерапия. 2013;33:24-32

23. Аверин Е.Е. Безопасность торасемида в комплексной терапии хронической сердечной недостаточности: результаты рандомизированного перекрестного исследования. Медицинский совет. 2016;13:81-4. DOI: 10.21518/2079-701X-2016-13-81-84

24. Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide Diuretics, Potassium, and the Development of Diabetes: A Quantitative Review. Hypertension. 2006;48(2):219–24. DOI: 10.1161/01.HYP.0000231552.10054.aa

25. Goldner MG, Zarowitz H, Akgun S. Hyperglycemia and Glycosuria Due to Thiazide Derivatives Administered in Diabetes Mellitus. New England Journal of Medicine. 1960;262(8):403–5. DOI: 10.1056/NEJM196002252620807

26. Пономарева А.И., Компаниец О.Г., Аверин Е.Е. Новые возможности фармакотерапии артериальной гипертензии. Русский Медицинский Журнал. 2012;20(25):1264-8

27. Chatterjee R, Yeh H-C, Edelman D, Brancati F. Potassium and risk of Type 2 diabetes. Expert Review of Endocrinology & Metabolism. 2011;6(5):665–72. DOI: 10.1586/eem.11.60

28. Rowe JW, Tobin JD, Rosa RM, Andres R. Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism. 1980;29(6):498–502. DOI: 10.1016/0026-0495(80)90074-8

29. Sagild U, Andersen V, Andreasen PB. Glucose Tolerance and Insulin Responsiveness in Experimental Potassium Depletion. Acta Medica Scandinavica. 2009;169(3):243–51. DOI: 10.1111/j.09546820.1961.tb07829.x

30. Ekmekcioglu C, Elmadfa I, Meyer AL, Moeslinger T. The role of dietary potassium in hypertension and diabetes. Journal of Physiology and Biochemistry. 2016;72(1):93–106. DOI: 10.1007/s13105015-0449-1

31. Helderman JH, Elahi D, Andersen DK, Raizes GS, Tobin JD, Shocken D et al. Prevention of the Glucose Intolerance of Thiazide Diuretics by Maintenance of Body Potassium. Diabetes. 1983;32(2):106–11. DOI: 10.2337/diab.32.2.106

32. Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Diet and risk of clinical diabetes in women. The American Journal of Clinical Nutrition. 1992;55(5):1018–23. DOI: 10.1093/ajcn/55.5.1018

33. Chatterjee R, Colangelo LA, Yeh HC, Anderson CA, Daviglus ML, Liu K et al. Potassium intake and risk of incident type 2 diabetes mellitus: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetologia. 2012;55(5):1295–303. DOI: 10.1007/s00125-012-2487-3

34. Chatterjee R, Yeh H-C, Shafi T, Selvin E, Anderson C, Pankow JS et al. Serum and Dietary Potassium and Risk of Incident Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities (ARIC) Study. Archives of Internal Medicine. 2010;170(19):1745–51. DOI: 10.1001/archinternmed.2010.362

35. DeFronzo RA, Felig P, Ferrannini E, Wahren J. Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. American Journal of Physiology-Endocrinology and Metabolism. 1980;238(5):E421–7. DOI: 10.1152/ajpendo.1980.238.5.E421

36. Cappuccio FP, Buchanan LA, Ji C, Siani A, Miller MA. Systematic review and meta-analysis of randomised controlled trials on the effects of potassium supplements on serum potassium and creatinine. BMJ Open. 2016;6(8):e011716. DOI: 10.1136/bmjopen-2016-011716

37. Аверин Е.Е., Никитин А.Э., Никитин И.Г., Созыкин А.В. Место рамиприла в современных рекомендациях по ведению пациентов с сердечно-сосудистыми заболеваниями. Медицинский совет. 2018;21:34-41. DOI: 10.21518/2079-701X-2018-21-34-41

38. Аверин Е.Е. Безопасность комплексной терапии хронической сердечной недостаточности: результаты рандомизированного, перекрестного исследования БАСТион. Международный журнал сердца и сосудистых заболеваний. 2016;4(11):40-6

39. Аверин Е.Е. Социально-правовые аспекты реабилитации кардиологических пациентов. Врач. 2010;7:19-22

40. de Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in Man: Implications for Health and Disease. Physiological Reviews. 2015;95(1):1–46. DOI: 10.1152/physrev.00012.2014

41. Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnesium Research. 2004;17(2):126–36. PMID: 15319146

42. Günther T. The biochemical function of Mg2+ in insulin secretion, insulin signal transduction and insulin resistance. Magnesium Research. 2010;23(1):5–18. DOI: 10.1684/mrh.2009.0195

43. Champagne CM. Magnesium in Hypertension, Cardiovascular Disease, Metabolic Syndrome, and Other Conditions: A Review. Nutrition in Clinical Practice. 2008;23(2):142–51. DOI: 10.1177/0884533608314533

44. Wester PO. Magnesium. The American Journal of Clinical Nutrition. 1987;45(5):1305–12. DOI: 10.1093/ajcn/45.5.1305

45. Belin RJ, He K. Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome. Magnesium Research. 2007;20(2):107–29. PMID: 18062585

46. Song Y, Liu S. Magnesium for cardiovascular health: time for intervention. The American Journal of Clinical Nutrition. 2012;95(2):269–70. DOI: 10.3945/ajcn.111.031104

47. Ayuk J, Gittoes NJ. Contemporary view of the clinical relevance of magnesium homeostasis. Annals of Clinical Biochemistry. 2014;51(2):179–88. DOI: 10.1177/0004563213517628

48. Whang R, Ryder KW. Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. JAMA. 1990;263(22):3063–4. PMID: 2342219

49. Aliaga IL, Miller DL, Wilson HD, Schedl HP. Effects of resection on absorption and secretion of divalent cations by small intestine of rat. The American Journal of Clinical Nutrition. 1990;52(5):867– 71. DOI: 10.1093/ajcn/52.5.867

50. Graham LA, Caesar JJ, Burgen AS. Gastrointestinal absorption and excretion of Mg 28 in man. Metabolism: Clinical and Experimental. 1960;9:646–59. PMID: 13848379

51. de Baaij JHF, Hoenderop JGJ, Bindels RJM. Regulation of magnesium balance: lessons learned from human genetic disease. Clinical Kidney Journal. 2012;5(Suppl 1):i15–24. DOI: 10.1093/ndtplus/sfr164

52. Peacock JM, Folsom AR, Arnett DK, Eckfeldt JH, Szklo M. Relationship of Serum and Dietary Magnesium to Incident Hypertension. Annals of Epidemiology. 1999;9(3):159–65. DOI: 10.1016/S10472797(98)00040-4

53. Ford ES, Mokdad AH. Dietary Magnesium Intake in a National Sample of U.S. Adults. The Journal of Nutrition. 2003;133(9):2879–82. DOI: 10.1093/jn/133.9.2879

54. Bhatt SP, Khandelwal P, Nanda S, Stoltzfus JC, Fioravanti GT. Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease. Respiratory Medicine. 2008;102(7):999–1003. DOI: 10.1016/j.rmed.2008.02.010

55. Sarrafzadegan N, Khosravi-Boroujeni H, Lotfizadeh M, Pourmogaddas A, Salehi-Abargouei A. Magnesium status and the metabolic syndrome: A systematic review and meta-analysis. Nutrition. 2016;32(4):409–17. DOI: 10.1016/j.nut.2015.09.014

56. Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs DR et al. Magnesium Intake in Relation to Systemic Inflammation, Insulin Resistance, and the Incidence of Diabetes. Diabetes Care. 2010;33(12):2604–10. DOI: 10.2337/dc10-0994

57. Paolisso G, Scheen A, D’Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia. 1990;33(9):511–4. DOI: 10.1007/BF00404136

58. Simmons D, Joshi S, Shaw J. Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome. Diabetes Research and Clinical Practice. 2010;87(2):261–6. DOI: 10.1016/j.diabres.2009.11.003

59. Chambers EC, Heshka S, Gallagher D, Wang J, Pi-Sunyer FX, Pierson RN. Serum Magnesium and Type-2 Diabetes in African Americans and Hispanics: A New York Cohort. Journal of the American College of Nutrition. 2006;25(6):509–13. DOI: 10.1080/07315724.2006.10719566

60. Xun P, Wu Y, He Q, He K. Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a metaanalysis of prospective cohort studies. The American Journal of Clinical Nutrition. 2013;98(6):1543–54. DOI: 10.3945/ajcn.113.065565

61. Çilliler AE, Öztürk Ş, Özbakır Ş. Serum Magnesium Level and Clinical Deterioration in Alzheimer’s Disease. Gerontology. 2007;53(6):419– 22. DOI: 10.1159/000110873

62. Reffelmann T, Ittermann T, Dörr M, Völzke H, Reinthaler M, Petersmann A et al. Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis. 2011;219(1):280–4. DOI: 10.1016/j.atherosclerosis.2011.05.038

63. Fang X, Wang K, Han D, He X, Wei J, Zhao L et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and allcause mortality: a dose–response meta-analysis of prospective cohort studies. BMC Medicine. 2016;14(1):210. DOI: 10.1186/s12916016-0742-z

64. Guasch-Ferré M, Bulló M, Estruch R, Corella D, Martínez-González MA, Ros E et al. Dietary Magnesium Intake Is Inversely Associated with Mortality in Adults at High Cardiovascular Disease Risk. The Journal of Nutrition. 2014;144(1):55–60. DOI: 10.3945/jn.113.183012

65. Sanjuliani AF, de Abreu Fagundes VG, Francischetti EA. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. International Journal of Cardiology. 1996;56(2):177–83. DOI: 10.1016/0167-5273(96)02716-7

66. Adamopoulos C, Pitt B, Sui X, Love TE, Zannad F, Ahmed A. Low serum magnesium and cardiovascular mortality in chronic heart failure: A propensity-matched study. International Journal of Cardiology. 2009;136(3):270–7. DOI: 10.1016/j.ijcard.2008.05.006

67. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S. Protective role of magnesium in cardiovascular diseases: a review. Molecular and Cellular Biochemistry. 2002;238(1/2):163–79. DOI: 10.1023/A:1019998702946

68. Hruby A, O’Donnell CJ, Jacques PF, Meigs JB, Hoffmann U, McKeown NM. Magnesium Intake Is Inversely Associated With Coronary Artery Calcification. JACC: Cardiovascular Imaging. 2014;7(1):59– 69. DOI: 10.1016/j.jcmg.2013.10.006

69. Jee SH, Miller ER, Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. American Journal of Hypertension. 2002;15(8):691–6. PMID: 12160191

70. Bo S, Pisu E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Current Opinion in Lipidology. 2008;19(1):50–6. DOI: 10.1097/MOL.0b013e3282f33ccc

71. Uzui H, Lee J-D. Role of magnesium in hypertension therapy. Clinical Calcium. 2005;15(11):117–22. DOI: CliCa051118791884

72. Das UN. Essential fatty acids: biology and their clinical implications. Asia Pacific Journal of Pharmacology. 1991;6:317–30

73. Touyz R. Role of magnesium in the pathogenesis of hypertension. Molecular Aspects of Medicine. 2003;24(1–3):107–36. DOI: 10.1016/S0098-2997(02)00094-8

74. Resnick LM. Magnesium in the pathophysiology and treatment of hypertension and diabetes mellitus: where are we in 1997? American Journal of Hypertension. 1997;10(3):368–70. DOI: 10.1016/S0895-7061(97)00021-6

75. Preuss HG. Diet, genetics and hypertension. Journal of the American College of Nutrition. 1997;16(4):296–305. DOI: 10.1080/07315724.1997.10718690

76. Dyckner T, Wester PO. Relation between Potassium, Magnesium and Cardiac Arrhythmias. Acta Medica Scandinavica Suppl. 2009;209(647):163–9. DOI: 10.1111/j.0954-6820.1981.tb02652.x